206 - Future of Vaccines: Applying Lessons From the COVID-19 Pandemic to the Development of New Pediatric Vaccines

Saturday, October 22, 2022

10:30 AM – 11:45 AM US ET

Location: 143 ABC

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Moderator(s)

William Steinbach, MD

Robert H. Fiser, Jr., MD Endowed Chair in Pediatrics Chair, Department of Pediatrics Associate Dean for Child Health College of Medicine, University of Arkansas for Medical Sciences Pediatrician-in-Chief, Arkansas Children’s
Arkansas Children's, University of Arkansas for Medical Sciences
Little Rock, AR, United States

Disclosure(s): Sfunga Therapeutics: Advisor/Consultant (Ongoing)
Tony Moody, MD

Professor of Pediatrics and Immunology
Duke University
Durham, NC, United States

Disclosure(s): Abcam: Advisor/Consultant (Ongoing); Grid Therapeutics: I am a co-holder of the patent for GT103 (Ongoing), Ownership Interest (Ongoing), Stocks/Bonds (Ongoing); GSK: Advisor/Consultant (Ongoing); PHITONEX: Advisor/Consultant (Terminated)

Faculty(s)

Lisa Cranmer, MD, MPH

Assistant Professor
Emory University and Childrens Healthcare of Atlanta
Decatur, GA, United States

Disclosure(s): No financial relationships to disclose

Slides
Hana El Sahly, MD

Professor
Molecular Virology and Microbiology
Baylor College of Medicine
Houston, TX, United States

Disclosure(s): No financial relationships to disclose

Slides
Andrea Berry, MD

Associate Professor of Pediatrics and Medicine
Center for Vaccine Development and Global Health
University of Maryland School of Medicine
Baltimore, Maryland, United States

Disclosure(s): No financial relationships to disclose

Slides

Disclosure(s):

William Steinbach, MD: Sfunga Therapeutics: Advisor/Consultant (Ongoing)

Tony Moody, MD: Abcam: Advisor/Consultant (Ongoing); Grid Therapeutics: I am a co-holder of the patent for GT103 (Ongoing), Ownership Interest (Ongoing), Stocks/Bonds (Ongoing); GSK: Advisor/Consultant (Ongoing); PHITONEX: Advisor/Consultant (Terminated)

Lisa M. Cranmer, MD, MPH: No financial relationships to disclose

Hana M. El Sahly, MD: No financial relationships to disclose

Andrea A. Berry, MD: No financial relationships to disclose

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 contact hours of pharmacy CE
ACPE Number: JA0007082-0000-22-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

define the state of tuberculosis vaccination in children;
describe the state of newer mRNA vaccines for other respiratory viruses;
discuss the state of malaria vaccination in children

Presentations:

10:30 AM – 10:55 AM US ET

Tuberculosis Vaccination
Speaker: Lisa M. Cranmer, MD, MPH – Emory University and Childrens Healthcare of Atlanta
10:55 AM – 11:20 AM US ET

mRNA Vaccines Against Respiratory Viruses
Speaker: Hana M. El Sahly, MD – Baylor College of Medicine
11:20 AM – 11:45 AM US ET

Malaria Vaccination in Children
Speaker: Andrea A. Berry, MD – University of Maryland School of Medicine